Literature DB >> 9060837

Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms.

A López-Candales1, D R Holmes, S Liao, M J Scott, S A Wickline, R W Thompson.   

Abstract

Abdominal aortic aneurysms (AAAs) are characterized by structural deterioration of the aortic wall leading to progressive aortic dilatation and eventual rupture. The histopathological changes in AAAs are particularly evident within the elastic media, which is normally dominated by vascular smooth muscle cells (SMCs). To determine whether a decrease in vascular SMCs contributes to medial degeneration, we measured SMC density in 21 normal and pathological human abdominal aortic tissue specimens using immunohistochemistry for alpha-SMC actin and direct cell counts (medial SMCs per high-power field (HPF)). Medial SMC density was not significantly different between normal aorta (n = 5; 199.5 +/- 14.9 SMCs/HPF) and atherosclerotic occlusive disease (n = 6; 176.4 +/- 13.9 SMCs/HPF), but it was reduced by 74% in AAA (n = 10; 50.9 +/- 6.1 SMCs/HPF; P < 0.01 versus normal aorta). Light and electron microscopy revealed no evidence of overt cellular necrosis, but SMCs in AAAs exhibited ultrastructural changes consistent with apoptosis. Using in situ end-labeling (ISEL) of fragmented DNA to detect apoptotic cells, up to 30% of aortic wall cells were ISEL positive in AAAs. By double-labeling techniques, many of these cells were alpha-actin-positive SMCs distributed throughout the degenerative media. In contrast, ISEL-positive cells were observed only within the intimal plaque in atherosclerotic occlusive disease. The amount of p53 protein detected by immunoblotting was increased nearly fourfold in AAA compared with normal aorta and atherosclerotic occlusive disease (P < 0.01), and immunoreactive p53 was localized to lymphocytes and residual SMCs in the aneurysm wall. Using reverse transcription polymerase chain reaction assays a substantial amount of p53 mRNA expression was observed in AAAs. These results demonstrate that medial SMC density is significantly decreased in human AAA tissues associated with evidence of SMC apoptosis and increased production of p53, a potential mediator of cell cycle arrest and programmed cell death. Given the role that SMCs normally play in maintaining medial architecture and in arterial wall matrix remodeling, the induction of SMC apoptosis likely makes an important contribution to the evolution of aneurysm degeneration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060837      PMCID: PMC1857880     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  74 in total

1.  Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways.

Authors:  M R Bennett; G I Evan; S M Schwartz
Journal:  Circ Res       Date:  1995-08       Impact factor: 17.367

2.  Death by any other name.

Authors:  S M Schwartz; M R Bennett
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 3.  Defining apoptosis.

Authors:  D Hockenbery
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

4.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Agents Actions       Date:  1994-10

Review 5.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

6.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Authors:  R W Thompson; D R Holmes; R A Mertens; S Liao; M D Botney; R P Mecham; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts.

Authors:  M M Kockx; B A Cambier; H E Bortier; G R De Meyer; S C Declercq; P A van Cauwelaert; J Bultinck
Journal:  Histopathology       Date:  1994-10       Impact factor: 5.087

8.  In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note.

Authors:  B Grasl-Kraupp; B Ruttkay-Nedecky; H Koudelka; K Bukowska; W Bursch; R Schulte-Hermann
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

9.  Social consequences of psychiatric disorders, I: Educational attainment.

Authors:  R C Kessler; C L Foster; W B Saunders; P E Stang
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

10.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.

Authors:  T Freestone; R J Turner; A Coady; D J Higman; R M Greenhalgh; J T Powell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

View more
  127 in total

Review 1.  Three-dimensional microstructural changes in murine abdominal aortic aneurysms quantified using immunofluorescent array tomography.

Authors:  Sanaz Saatchi; Junya Azuma; Nishey Wanchoo; Stephen J Smith; Paul G Yock; Charles A Taylor; Philip S Tsao
Journal:  J Histochem Cytochem       Date:  2011-12-01       Impact factor: 2.479

2.  Nicotine: linking smoking to abdominal aneurysms.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Nat Med       Date:  2012-06-06       Impact factor: 53.440

Review 3.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

Review 4.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 5.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 6.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

7.  T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.

Authors:  Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 8.  Biomechanical Rupture Risk Assessment: A Consistent and Objective Decision-Making Tool for Abdominal Aortic Aneurysm Patients.

Authors:  T Christian Gasser
Journal:  Aorta (Stamford)       Date:  2016-04-01

9.  LncRNA CRNDE affects the proliferation and apoptosis of vascular smooth muscle cells in abdominal aortic aneurysms by regulating the expression of Smad3 by Bcl-3.

Authors:  Kun Li; Mingzhe Cui; Kewei Zhang; Guoquan Wang; Shuiting Zhai
Journal:  Cell Cycle       Date:  2020-04-02       Impact factor: 4.534

10.  AKT2 confers protection against aortic aneurysms and dissections.

Authors:  Ying H Shen; Lin Zhang; Pingping Ren; Mary T Nguyen; Sili Zou; Darrell Wu; Xing Li Wang; Joseph S Coselli; Scott A LeMaire
Journal:  Circ Res       Date:  2012-12-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.